Table 1. AML patient samples selected... | American Society of Hematology

Table 1.

AML patient samples selected for cell sorting and xenotransplantation studies

AML	CD200 (% of blasts)	CD34 (% of blasts)	CD45^dimCD200⁺ (% of MNCs)	CD200 sort	Karyotype	NPM1	FLT3-ITD
AML samples expressing CD200 on ≥10% of blasts
3	52	10	20	Standard	Normal	Mutated	Positive
5	70	21	28	Standard	Normal	Mutated	Positive
11	10	10	3	Standard	Normal	Mutated	Negative
13	25	3	4	Standard	Normal	Mutated	Negative
21	48	2	4	Standard	Normal	Mutated	Negative
22	35	<1	35	Standard	Normal	Mutated	Negative
30	96	84	45	Standard	Normal	WT	Negative
47	85	75	40	Standard	Abnormal	WT	Negative
51	77	89	76	Standard	Abnormal	WT	Negative
63	77	35	85	Standard	unknown	Mutated	Positive
AML samples expressing CD200 on <5% of blasts
27	1	<1	1	Standard	Normal	WT	Negative
36	<1	<1	<1	Standard	Abnormal	Mutated	Negative
38	4	4	2	Standard	Abnormal	Mutated	Negative
44	3	100	4	Standard	Abnormal	WT	Negative
45	<1	90	<1	Standard	Abnormal	WT	Negative
54	<1	<1	<1	Standard	Abnormal	WT	Negative
AML samples with mixed leukemic and multilineage grafts
7	42	5	2	Expanded	Normal	Mutated	Negative
2	61	15	16	Expanded	Normal	Mutated	Positive

AML	CD200 (% of blasts)	CD34 (% of blasts)	CD45^dimCD200⁺ (% of MNCs)	CD200 sort	Karyotype	NPM1	FLT3-ITD
AML samples expressing CD200 on ≥10% of blasts
3	52	10	20	Standard	Normal	Mutated	Positive
5	70	21	28	Standard	Normal	Mutated	Positive
11	10	10	3	Standard	Normal	Mutated	Negative
13	25	3	4	Standard	Normal	Mutated	Negative
21	48	2	4	Standard	Normal	Mutated	Negative
22	35	<1	35	Standard	Normal	Mutated	Negative
30	96	84	45	Standard	Normal	WT	Negative
47	85	75	40	Standard	Abnormal	WT	Negative
51	77	89	76	Standard	Abnormal	WT	Negative
63	77	35	85	Standard	unknown	Mutated	Positive
AML samples expressing CD200 on <5% of blasts
27	1	<1	1	Standard	Normal	WT	Negative
36	<1	<1	<1	Standard	Abnormal	Mutated	Negative
38	4	4	2	Standard	Abnormal	Mutated	Negative
44	3	100	4	Standard	Abnormal	WT	Negative
45	<1	90	<1	Standard	Abnormal	WT	Negative
54	<1	<1	<1	Standard	Abnormal	WT	Negative
AML samples with mixed leukemic and multilineage grafts
7	42	5	2	Expanded	Normal	Mutated	Negative
2	61	15	16	Expanded	Normal	Mutated	Positive

FLT3-ITD, Fms-like tyrosine kinase 3–internal tandem duplication.